GlassScriptPhysician profile
Christopher J Mancuso
NPI 1568464378
$3,049.32
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $36.81 · 2021: $1,200 · 2022: $25.02 · 2023: $430 · 2024: $1,358.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,218 · Food and Beverage: $531 · Debt Forgiveness: $38.71.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,218.11 |
| Food and Beverage | $530.67 |
| Debt Forgiveness | $38.71 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $1,441.43 | 2023-2024 | Arthrex |
| Novus Surgical Solutions LLC | $1,200.00 | 2021 | |
| Novus Surgical Consultants | $283.50 | 2022-2024 | |
| Janssen Biotech, INC. | $48.87 | 2023 | Tremfya |
| Baxter Healthcare | $38.71 | 2023 | |
| Mayne Pharma Commercial LLC | $28.13 | 2019 | |
| Heraeus Medical, LLC. | $8.68 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Mancuso listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.